Xenoport Inc $5.08

down 0.00


29/8/2014 04:00 PM  |  NASDAQ : XNPT  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get XNPT Trend Analysis - it has underperformed the S&P 500 by 18%

Partner Headlines

  1. Clinton Group Issues Release Reporting Availability of Proxy Materials ...

    Benzinga
  2. XenoPort Files Definitive Proxy Materials and Mails Letter to Stockholders

    Benzinga
  3. US Stock Futures Tumble; All Eyes On P&G, Honeywell Earnings

    Benzinga
  4. XenoPort Prices 12M Share Offering at $6.00/Share

    Benzinga
  5. XenoPort to Offer 10M Shares Common Stock

    Benzinga
  6. XenoPort Reports Feedback from FDA on XP23829

    Benzinga
  7. XenoPort Responds to Clinton Group Call for New CEO

    Benzinga
  8. Jeryl L Hilleman Named Ocera Therapeutics CFO

    Benzinga
  9. XenoPort Inc. Reports Operating Results (10-Q)

    GuruFocus
  10. UPDATE: Piper Jaffray Downgrades XenoPort to Neutral on Drug Commercialization ...

    Benzinga
  11. UPDATE: Deutsche Bank Reiterates Buy Rating, Raises PT on XenoPort

    Benzinga
  12. Socks Hitting 52-Week Highs

    Benzinga
  13. XenoPort Inc. Reports Operating Results (10-Q)

    GuruFocus
  14. Social Media Outlook for Friday July 27 (NYT, XNPT, GDOT, STRA)

    Benzinga
  15. XenoPort Announces Pricing of Public Offering of 6.15M Shares at $6.50

    Benzinga
  16. XenoPort Announces Proposed Public Offering of Common Stock

    Benzinga
  17. XenoPort Announces Initiation of a Phase 1 Clinical Trial of XP23829, a ...

    Benzinga
  18. From Earlier, GSK and XenoPort Receive FDA Approval for Horizant® for Postherpetic ...

    Benzinga
  19. UPDATE: Credit Suisse Initiates Outperform, $7 PT on XenoPort; Valuation ...

    Benzinga
  20. Xenoport Cuts 18 Jobs, Sees Charges of 1.4M, Names Vincent Angotti Operating ...

    Benzinga
  21. UPDATE: Deutsche Bank Lowers Target on XenoPort to $7

    Benzinga
  22. Wedbush Lowers PT on XenoPort to $15

    Benzinga
Trading Center